Peter Adamson, MD

Peter Adamson, MD

Pediatric Hematology & Oncology Philadelphia, PA

Chair, Children's Oncology Group Chief, Division of Clinical Pharmacology & Therapeutics

Office Address

Office Map
  • 3501 Civic Center Blvd, CTRB 10060
    Children's Hospital Of Philadelphia
    Philadelphia, PA 19104
    Phone: (215) 590-6359
    Fax: (215) 590-7544

Dr. Adamson's Clinical Specialties & Interests

  • Pediatric Hematology & Oncology: General Pediatric Hematology & Oncology

Dr. Adamson's Faculty Appointments & Work History

  • ProfessorThe Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine
    Associate Professor of Pediatrics (1999-2006); Associate Professor of Pharmacology (2001-2006); Director, Office of Clinical and Translational Research (2005-present); Professor of Pediatrics and Pharmacology (2006-present)
  • DirectorThe Joseph Stokes, Jr. Research Institute of The Children's Hospital of Philadelphia
    Philadelphia, PA
  • Attending PhysicianPediatric Oncology Branch, NCI
  • InvestigatorNational Cancer Institute
    Bethesda, MD
    Research Scholar (1992-1994); Investigator (1995-1999)

Dr. Adamson's Education & Medical Training

  • NIH Clinical CtrNIH Clinical CtrFellowship, Biotechnology
  • NIH Clinical CtrNIH Clinical CtrFellowship, Pediatric Hematology/Oncology
  • Children's Hospital of PhiladelphiaChildren's Hospital of PhiladelphiaFellowship, Medical Oncology
  • Children's Hospital of PhiladelphiaChildren's Hospital of PhiladelphiaResidency, Pediatrics
  • Cornell Univ Med CollWeill Cornell Medical College of Cornell UniversityMedical School
  • Wesleyan UniversityWesleyan UniversityOther Training, BA, Chemistry

Dr. Adamson's Certifications & Licensure

  • PA State Medical LicensePA State Medical License1986 - 2014
  • American Board of PediatricsAmerican Board of PediatricsPediatrics, 1988
  • American Board of PediatricsAmerican Board of PediatricsPediatric Hematology-Oncology, 1990

Dr. Adamson's Awards, Honors, & Recognition

  • National Cancer InstituteSpecial Recognition AwardNational Cancer Institute, 2005
  • Children's Cancer Foundation Research Scholar1992
  • Overall excellence in clinical and interpersonal skills1987
  • Register to See 4 More...

Dr. Adamson's Clinical Trials

Dr. Adamson's Publications & Presentations

PubMed | Citations by Web of Science®

Journal Articles

  • Acute pancreatitis following ifosfamide.Izraeli S, Adamson PC, Blaney SM, Balis FM, Cancer; 74(5):1627-1628
  • A phase I trial of amifostine (WR-2721) and melphalan in pediatric patients with advanced neoplastic disease.Adamson PC, Balis FM, Belasco JE, Lange B, Berg SL, Blaney SM, Craig C, Poplack DG, Cancer Res; 55:4069-4072
  • Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey.Adamson PC, Murphy RF, Godwin KA, Ulm EH, Balis FM, Cancer Res; 55(3):482-485
  • Register to See 97 More...

Books/Book Chapters

  • Drug resistance in leukemia and lymphoma: The clinical value of laboratory studies.Chapter: Pharmacologic factors involved in the response to chemotherapy: apparent versus intrinsic drug resistancePage 33 - 39
    Adamson P, Poplack D
    Editors: Kaspers GJL, Pieters R, Twentyman PR, Wiesenthal LM, Veerman AJP.Harwood Academic Publishers, Chur, Switzerland
  • Cancer in the Nervous System.Chapter: Pharmacologic approaches to treatment of meningeal metastasesPage 291 - 301
    Adamson PC, Poplack DG
    Editors: Levin VA.Churchill Livingstone, New York
  • Making better drugs for children with cancer.
    National Cancer Policy Board (U.S.). Committee on Shortening the Time Line for New Cancer Treatments., Adamson PC, Weiner SL, Simone JV, Gelband H
    Editors: .National Academies Press, Washington, D.C
  • Register to See 10 More...


  • Phase I study of sorafenib in children with refractory solid tumors: A Children's Oncology Group Phase I Consortium trial.Widemann BC, Fox E, Adamson PC, Baruchel S, Kim A, Ingle AM, Bender JG, Stempak D, Balis FM, Blaney SM, ASCO Meeting Abstracts
  • Modeling MLN8237, an aurora kinase a inhibitor, with irinotecan (IRN) and temozolomide (TMZ) in neuroblastoma (NB).Lipsitz EG, Nguyen V, Zhao H, Ecsedy J, Maris JM, Adamson PC, Mosse YP, ASCO Meeting Abstracts; 28(15_suppl):10593. PMID
  • A pediatric phase I trial and pharmacokinetic study of MLN8237, an oral selective small molecule inhibitor of aurora a kinase: A Children's Oncology Group Phase I Consortium study.Mosse YP, Lipsitz EG, Maris JM, Weigel B, Adamson PC, Ingle M, Ahern CH, Blaney S, ASCO Meeting Abstracts; 28(15_suppl):9529
  • Register to See 15 More...


  • Early Phase Cancer Drug Development in Children.Philadelphia, PA, 2007; Boulder, CO, 2008
  • Development of Targeted Therapy for Children with Cancer.Ely Brent Visiting Professor The Children’s Hospital, Denver Cancer Center Rounds
  • New Agents for Children with Cancer.Pediatric Grand Rounds, Denver, CO
  • Register to See 27 More...

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • AmeriHealth Direct POS
  • AmeriHealth Direct POS Value Network
  • Amerihealth HMO
  • AmeriHealth HMO Value Network
  • AmeriHealth PPO
  • AmeriHealth PPO Value Network
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA Open Access
  • Cofinity PPO
  • Coventry Carelink Health Plans PPO
  • First Health PPO
  • Great West PPO
  • Health Net Arizona HMO
  • Health Net Arizona PPO/POS
  • Horizon BCBS Direct Access
  • Horizon BCBS HMO
  • Horizon BCBS POS
  • Horizon BCBS PPO
  • Humana ChoiceCare Network PPO
  • IBC Keystone HMO / POS
  • IBC Personal Choice PPO
  • Multiplan PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • QualCare HMO
  • QualCare PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Adamson's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV